Oct 12 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ENTERED INTO A GLOBAL, EXCLUSIVE LICENSE WITH SPARX GROUP
- LICENSE TO DEVELOP A WORLD-FIRST INKT CELL THERAPY TARGETING A VALIDATED TARGET
Oct 12 (Reuters) - Arovella Therapeutics Ltd (ALA) : ENTERED...
Add to My Watchlist
What is My Watchlist?